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1. Introduction 
Palmoplantar keratosis or palmoplantar keratoderma (PPK) constitutes a heterogeneous 
group of disorders characterized by excessive epidermal thickening of the palms and soles 
of affected individuals [1]. PPK can be characterized as either inherited or acquired. 
Transgredient PPK extends beyond palmoplantar skin, contiguously or as callosities on 
pressure points on the fingers or knuckles, or elsewhere. Typical pathohistological findings 
of PPK are orthokeratotic hyperkeratosis, hyper- or hypogranulosis and acanthosis. These 
changes are non-specific and found in many types of PPK. 
PPK is classified clinically as diffuse, focal, striate, or punctuate and develops either in 
isolation or in association with other cutaneous or extracutaneous manifestations. The 
diffuse type consists of uniform involvement of the palmoplantar surface. The focal type 
consists of localized areas of hyperkeratosis located mainly on pressure points and sites of 
recurrent friction. The striate type presents with linear hyperkeratosis on the palms and 
soles. The punctate type features multiple small, hyperkeratotic papules, spicules, or 
nodules on the palms and soles. These tiny keratoses may involve the entire palmoplantar 
surface or may be restricted to certain locations. 
2. Diffuse PPK 
2.1. Unna-Thost PPK 
Unna-Thost PPK is inherited in an autosomally dominant manner without associated organ 
involvement. The condition may manifest in the first few months of life but is usually well 
developed by age 3-4 years. The disease develops in early childhood and persists 
throughout life. Clinically, there is hyperkeratosis on the palms and soles. Unna-Thost PPK 
is characterized by a well-demarcated, symmetric, often "waxy" hyperkeratosis involving 
the whole of the palms and soles. It is usually nontransgredient, with a sharp demarcation 
of the lesions at the wrists. Aberrant keratotic lesions may appear in the dorsum of the 
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hands, feet, knees, and elbows. The dorsa of the fingers may be involved with a 
sclerodermalike thickening of the distal digit. A cobblestone hyperkeratosis of the knuckles 
may be seen. Nails may be thickened. 
Histological findings include orthokeratotic hyperkeratosis associated with hypergranulosis 
or hypogranulosis and moderate acanthosis. Molecular biology features include linkage to 
type II keratin locus on band 12q11-13, corresponding to a keratin 1 gene mutation. 
Treatment includes salicylic acid, 50% propylene glycol in water under plastic occlusion 
several nights per week, and lactic acid- and urea-containing creams and lotions; all have 
been shown to be helpful. Mechanical debridement with a blade may also be useful. Oral 
retinoid therapy has had variable effects. 
2.2. Vörner PPK 
This type is inherited in an autosomal dominant fashion. It has an estimated prevalence of at 
least 4.4 cases per 100,000 population in Northern Ireland. Onset occurs in the first few 
months of life, but the disease is usually well developed by age 3-4 years. A well-
demarcated, symmetric thick, yellow hyperkeratosis is present over the palms and soles, 
often with a "dirty" snakeskin appearance due to underlying epidermolysis [2]. An 
erythematous band is frequently present at the periphery of the keratosis. The surface is 
often uneven and verrucous. Finally, it is usually nontransgredient, with a sharp 
demarcation of the lesions at the wrists. 
Histologically, keratinocytes show epidermolysis, hyperkeratosis, acanthosis, and 
papillomatosis. Perinuclear vacuolization and large keratohyalin granules are seen. Cellular 
breakdown in the spinous and granular cell layers sometimes leads to blister formation. 
Keratin 1 and keratin 9 mutations have also been reported. Treatment includes salicylic acid, 
50% propylene glycol in water under plastic occlusion several nights per week, and lactic 
acid- and urea-containing creams and lotions; all have been shown to be helpful. Mechanical 
debridement with a blade also may be useful. Oral retinoid therapy has had variable effects 
and may not benefit patients with certain genotype profiles, such as K1 mutations. 
Clinical features of Vörner PPK are very similiar to Unna-Thost PPK. Unna-Thost PPK may 
have a waxy appearance, compared with the dirty appearance of Vörner PPK. 
Hyperhidrosis and pitted keratolysis may be present with Unna-Thost PPK. Differentiation 
from Unna-Thost PPK can be made histopathologically, with the finding of epidermolysis. 
There is no epidermolysis or vacuolar changes in Unna-Thost PPK. 
2.3. Mal de Meleda 
Mal de Meleda is characterized by a diffuse, thick hyperkeratosis with a prominent 
erythematous border. This disease is characterized by early infancy onset and follows a 
progressive course with extension to the dorsal surfaces of the hands and feet. This 
condition is inherited in an autosomal recessive fashion. The prevalence is 1 case per 100,000 
population. The disease has its onset in early infancy and follows a progressive course. It 
was first described in inhabitants of the Adriatic Island of Meleda. 
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Mal de Meleda frequently presents with constrictive bands, perioral erythema, nail changes, 
and occasional brachydactyly, with a progressive clinical course throughout the patients’ 
lives. The main clinical characteristics are transgressive PPK, hyperhidrosis, and perioral 
erythema. Clinical dermatological features include diffuse, thick keratoderma with a 
prominent erythematous border. Lesions spread onto the dorsa of the hands and the feet 
(transgredient). Constricting bands are present around the digits and can result in 
spontaneous amputation. Well-circumscribed psoriasis-like plaques or lichenoid patches 
may be present on the knees and the elbows. Patients may have severe hyperhidrosis, 
possibly accompanied by malodor. Secondary bacterial and fungal infections are common. 
Other clinical features include: lingua plicata, syndactyly, hair on the palms and the soles, 
high-arched palate, and left-handedness. 
Histologic findings include orthokeratosis and normogranulosis without epidermolysis. 
Mutations in the gene SLURP1 located on chromosome 8q24.3 were identified as the cause 
of Mal de Meleda. Molecular biology features include mutations in the gene encoding 
SLURP1 found on band 8q24.3. 
2.4. Nagashima-type PPK 
Nagashima-type PPK is included in the diffuse autosomal recessive type of hereditary PPKs 
without associated features [3]. Nagashima-type PPK was first described in a report from 
Japan in 1977. Since then, more than 20 cases have been reported in Japan. Nagashima-type 
cases have been reported only in the Japanese literature; this type of PPK is not well known 
in Western countries, even though the existence of this disease is recognized. Therefore, the 
definition and characterization of this disease have not been well recognized globally. 
Onset of disease occurs between birth and age 3 years (Figures 1, 2). Because its clinical 
manifestations are similar to but milder than those of mal de Meleda, it was originally 
described as a mild form of Mal de Meleda. Mal de Meleda is much more severe than 
Nagashima-type. It usually involves perioral erythema and occasionally exhibits 
brachydactyly, nail abnormalities, and lichenoid plaques. Unlike Mal de Meleda, 
spontaneous amputation has never been observed in Nagashima type PPK. Furthermore, 
there is no evidence of a SLURP1 mutation in patients with Nagashima-type PPK. The 
results of genetic study suggested that Nagashima-type PPK is distinct from Mal de Meleda. 
2.5. Vohwinkel syndrome 
Vohwinkel syndrome (mutilating and diffuse PPK) is associated with various 
extracutaneous features, including ichthyosis and deafness. Onset occurs in infancy. 
Clinically, this condition manifests in infants as a honeycomblike keratosis of the palms and 
the soles. It becomes transgredient during childhood. Later-forming, constricting, fibrous 
bands appear on the digits and can lead to progressive strangulation and autoamputation. 
Starfish-shaped keratosis may occur on the knuckles of the fingers and toes, which is a 
characteristic feature of this disorder. Alopecia, hearing loss, spastic paraplegia, myopathy, 
ichthyosiform dermatosis, and nail abnormalities are other associated manifestations. Other 
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reported findings are deaf-mutism, congenital alopecia universalis, pseudopelade type 
alopecia, acanthosis nigricans, spastic paraplegia, myopathy, nail changes, mental 
retardation, bullous lesions on the soles, and seizures [4]. 
 
A 10-month-old Japanese girl presented with bilateral reddish, palmoplantar hyperkeratotic lesions on her palms and 
soles. The patient was otherwise healthy. 
(A) Right sole 
(B) Histopathological findings reveal orthokeratotic hyperkeratosis, hypergranulosis, acanthosis, and a mild 
lymphocytic infiltrate in the upper dermis of the palm. 
Figure 1. Nagashima-type PPK 
Histological findings include hyperkeratosis, acanthosis, and a thickened granular cell layer 
with retained nuclei in the stratum corneum. Molecular biology studies have confirmed that 
the most common mutation is found in the gene encoding connexin 26. This subtype is 
associated with hearing loss. In contrast, a mutation in the gene for loricrin is associated 
with mutilating keratoderma and ichthyosis but not deafness. The mode of inheritance for 
mutation in the loricrin and connexin 26 genes is autosomal dominant. Treatment includes 
oral retinoids. 
2.6. Bart-Pumphrey syndrome 
Bart-Pumphrey syndrome is an autosomal-dominant disorder characterized by knuckle 
pads, leukonychia, PPK and hearing loss. Onset occurs in infancy. PPK may be diffuse and 
striate, with accentuation of crease patterns and with a grainy surface [5]. Clinically, all 
neonates are hearing impaired from birth and develop diffuse PPK in childhood. 
Leukonychia and hyperkeratoses over the joints of the hand may also appear. 
Knuckle pads are circumscribed, with hyperkeratotic or fibrous growths over the dorsal 
aspects of the small joints of the hands or feet. Leukonychia that may be seen in Bart-
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Pumphrey syndrome is defined as whiteness of nails that can occur either in patches or 
involving the total nail. Large keratohyaline granules are found in the keratinocytes, and the 
keratohyaline-containing cells reflected light, resulting in a white nail appearence. 
Molecular biology studies reveal a new mutation in the gene that encodes connexin 26, 
which explains the clinical overlap with Vohwinkel syndrome. 
 
 
 
The patient's sister, a 3-year-old girl, had bilateral reddish palmoplantar hyperkeratotic lesions on the (A) soles and (B) 
palms. This family had no other significant medical history. 
Figure 2. Nagashima-type PPK 
2.7. Loricrin keratoderma 
The term “loricrin keratoderma” has been suggested to group patients with dominantly 
inherited PPK that has a different clinical presentation characterized by non-bullous 
congenital ichthyosiform erythroderma, progressive symmetric erythrokeratoderma, and 
the patients with Vohwinkel syndrome, carrying mutations in loricrin gene [6, 7]. In all 
loricrin keratoderma patients, the common signs are the palmoplantar honeycomb 
hyperkeratosis and ichthyosis. Collodion baby was sometimes reported independently from 
the clinical evolution of the patients. The originally described Vohwinkel syndrome, because 
of mutations in connexin 26 gene, shows: palmoplantar honeycomb hyperkeratosis; 
constricting fibrous bands encircling fingers or toes, characterized as pseudoainhum, 
leading to autoamputation of the fifth finger due to circulatory impairment; starfish-shaped 
hyperkeratotic lesions on the extensor surfaces; and high-tone deafness. By contrast, in 
loricrin keratoderma, the hearing impairment and starfish-shaped hyperkeratosis are absent 
and a generalized non-erythrodermic ichthyosis is described. 
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2.8. Clouston syndrome (Hidrotic ectodermal dysplasia)  
Clouston syndrome (hidrotic ectodermal dysplasia) is an autosomal dominant ectodermal 
dysplasia characterized by hypotrichosis, severe nail dystrophy, and PPK as well as 
hyperpigmentation of the skin over the large joints. Clinical features include diffuse 
papillomatous PPK (especially over pressure points of the palms and soles), dystrophic 
nails, and hypotrichosis. Thickened, hyperpigmented skin may also appear over the small 
and large joints, including the knuckles, elbows, and knees. Thickened, severely dystrophic 
nails develop, but they may be normal at birth. Universal sparsity of hair involves the scalp, 
eyebrows, eyelashes, and axillary and genital regions. Sensorineural deafness, polydactyly, 
syndactyly, clubbing of the fingers, mental retardation, dwarfism, photophobia, and 
strabismus are associated manifestations. 
Clouston syndrome reveals orthohyperkeratosis with a normal granular layer based on 
histopathological analysis of PPK. Ultrastructural studies of the hair of these patients 
demonstrate disorganization of hair fibrils with loss of the cuticular cortex. Positional 
cloning identifies GJB6 on chromosome 13q12 as the causative gene for Clouston syndrome 
[8].1GJB6 encodes connexin 30 (Cx30), which belongs to a family of cell membrane proteins, 
the connexins, which form gap junctions between neighbouring cells. 
2.9. Olmsted syndrome 
Olmsted syndrome is an uncommon genetic disorder with symmetrical, diffuse, 
transgredient, mutilating PPK and periorificial hyperkeratosis [9]. Most cases of this 
condition are sporadic, with the exception of one report of an autosomal dominant pattern 
of inheritance. Onset occurs in the first year of life. Clinically, PPK begins focally in infancy 
and then becomes diffuse and severe. Later findings include flexion deformities and 
constriction of the digits, sometimes leading to spontaneous amputation. Progressive, well-
defined perioral, perianal, and perineal hyperkeratotic plaques are present, as is 
onychodystrophy. Alopecia, deafness, nail dystrophy, and dental loss may be associated. 
Squamous cell carcinoma and malignant melanoma are also known to develop in the 
affected areas. Rare findings include large joint laxity, ichthyotic lesions, absent premolar 
teeth, hearing loss for high frequencies, and sclerosing cholangitis. 
Histological findings include hyperkeratosis without parakeratosis and mild acanthosis. 
Abnormal expression of keratin 5 and 14 has been reported. Treatment includes oral and 
topical retinoids. Full-thickness excision and skin grafting has also been reported to result in 
clinical improvement. 
2.10. Huriez syndrome 
Huriez syndrome is an autosomal dominant genodermatosis, characterized by the triad of 
congenital scleroatrophy of the distal extremities, PPK, and hypoplastic nail changes. The 
soles are not commonly involved. It was first described in two large pedigrees from 
northern France [10]. In addition to its occurrence in French patients, it has also been 
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reported in Tunisia, Germany and Italy [11]. Onset occurs in infancy. Clinical features 
include red, atrophic skin on the dorsal hands and feet at birth. Diffuse, mild keratoderma is 
more marked on the palms than the soles. Other clinical features are sclerodactyly and nail 
abnormalities (hypoplasia, fissuring, ridging, koilonychia). The age at the onset of skin 
cancer is much lower than in the general population, and tumors arise in the areas of the 
affected skin. Affected individuals carry a more than 100-fold higher risk for the 
development of aggressive squamous cell carcinoma of the skin. 
Histological findings include acanthosis, accentuation of the granular layer, and 
orthokeratosis. Langerhans cells are almost completely absent in the affected skin. Electron 
microscopy reveals normal dermoepidermal junctions and desmosomes; however, dense 
bundles of tonofilaments are seen in the epidermal layer. The granular layer shows large, 
coarse, clumped keratohyalin. Molecular biology findings include a mutation in the gene 
mapped to 4q23. 
2.11. Papillon-Lefèvre syndrome 
Papillon-Lefèvre syndrome is a rare disease characterized by skin lesions, which include 
PPK and hyperhidrosis with severe periodontal destruction involving both the primary and 
the permanent dentitions [12]. It is transmitted as an autosomal-recessive condition, and 
consanguinity of parents is evident in about one-third of the cases. This disease usually has 
its onset between the ages of 1 to 4 years. The male to female ratio is roughly equal. Its 
prevalence is estimated to be 1 to 4 per million in the general population with a carrier rate 
of 2 to 4 per 1000. 
Clinically, diffuse transgredient PPK may be observed, typically developing within the first 
3 years of life. Punctiform accentuation, particularly along the palmoplantar creases, may be 
seen. Unless treated, periodontosis results in severe gingivitis and loss of teeth by age 5 
years. No significant correlation has been demonstrated between the level of periodontal 
infection and the severity of skin affections, which supports the concept that these major 
components of this syndrome are unrelated to each other. Patients exhibit increased 
susceptibility to cutaneous and systemic infections. Scaly, psoriasiform lesions are often 
observed over the knees, elbows, and interphalangeal joints. Finally, patients may have 
malodorous hyperhidrosis. 
Histological findings include hyperkeratosis with irregular parakeratosis and moderate 
perivascular infiltration. Electron microscopic features include lipid-like vacuoles in 
corneocytes and granulocytes, a reduction in tonofilaments, and irregular keratohyalin 
granules. Molecular biology findings include mutations in the gene for cathepsin C, 
mapping to 11q14-q21, which are responsible for this syndrome. Cathepsin C is a lysosomal 
protease known to activate enzymes that are vital to the body's defenses. The susceptibility 
factor may involve defective immune function or pleiotropic effect of the single mutant 
Cathepsin C gene [13]. 
Treatment includes oral retinoids for the PPK. Elective extraction of involved teeth may 
prevent excess bone resorption. Appropriate antibiotic therapy may be required for 
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periodontitis and recurrent cutaneous and systemic infections. Treatment with acitretin 
starting at an early age shows promise in allowing patients to have normal adult dentition. 
Early treatment and compliance with the prevention program are the major determinants 
for preserving permanent teeth in young patients. By extracting all primary teeth and 
eradicating periodontal pathogens, the patient's adult teeth can erupt into a safe 
environment. Treatment may be more beneficial if it is started during the eruption and 
maintained during the development of the permanent teeth. Recommended therapy 
includes aggressive local measures to control plaque including rigorous oral hygiene, 
chlorhexidine mouth rinses, frequent professional prophylaxis, and periodic appropriate 
antibiotic therapy needed for long-term maintenance. 
2.12. Naxos disease 
Naxos disease is a rare autosomal recessive inherited association of right ventricular 
dysplasia/dilated cardiomyopathy with woolly hair and PPK [14]. The disease has an 
adverse prognosis, especially in young patients. In a long-term study of an unselected 
population of patients with Naxos disease it was shown that risk factors for sudden death 
include history of syncope, the appearance of symptoms, severely progressive disease of the 
right ventricle before the age of 35 years, and the involvement of the left ventricle [15]. 
Symptoms of right heart failure appear during the end stages of the disease. One-third of 
patients become symptomatic before the 30th year of life. In some cases, a few clinical 
findings of early heart disease can be detected during childhood. 
Clinically, a diffuse, nontransgredient keratoderma with an erythematous border appears 
during the first year of life. Woolly (dense, rough, and bristly) scalp hair is present at birth. 
Cardiac disease, manifested by arrhythmias, heart failure, or sudden death, becomes evident 
during and after late puberty. Other cutaneous manifestations include acanthosis nigricans, 
xerosis, follicular hyperkeratosis over the zygoma, and hyperhidrosis. In addition to the 
woolly hair at birth, PPK develops during the first year of life and cardiomyopathy is 
clinically manifested by adolescence with 100% penetrance. Patients present with syncope, 
sustained ventricular tachycardia or sudden death. 
Histological findings include hyperkeratosis, hypergranulosis, and acanthosis. Molecular 
biology findings include a mutation in the plakoglobin gene, mapping to 17q21, which is 
responsible for Naxos disease. Plakoglobin is an important component of cell-to-cell and 
cell-to-matrix adhesion complexes of many tissues, including the skin and cardiac junctions. 
It also plays a role in signaling in the formation of desmosomal junctions. Mutations in the 
plakoglobin gene may lead to detachment of the cardiac myocytes, resulting in myocyte 
death. Plakoglobin mutations may also lead to desmosomal junction fragility in hair shafts, 
explaining the clinical phenotype of woolly hair. 
The primary goal of treatment is the prevention of sudden cardiac death. Implantation of an 
automatic cardioverter defibrillator is indicated in patients who develop symptoms and/or 
structural progression, particularly before the age of 35 years. Antiarrhythmic drugs are 
indicated for preventing recurrence of episodes of sustained ventricular tachycardia. In an 
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attempt to control Naxos disease, systematic genetic screening of the populations at risk has 
been initiated and is starting to identify the heterozygous carriers of the plakoglobin gene 
mutation. 
3. Focal type 
The focal type is subclassified into focal PPK, focal palmoplantar and gingival keratosis, 
focal keratoderma with oral leukokeratosis, pachyonychia congenita type 1 (Jadassohn–
Lawandowsky type) and type 2 (Jackson–Lawler type), and focal PPK associated with 
esophageal carcinoma. Focal palmoplantar and gingival keratosis is characterized clinically 
by focal PPK with leukoplakic appearance on the labial surface of the attached gingival 
lesion, and histologically by focal epidermolytic PPK [16]. 
4. Striate type 
4.1. Striate PPK (Brunauer-Fohs-Siemens syndrome) 
Striate PPK (Brunauer-Fohs-Siemens syndrome) presents with linear hyperkeratosis on the 
palms and fingers and focal plaques on the plantar aspects of the feet. Onset occurs in 
infancy or the first few years of life. Striate PPK, woolly hair, and left ventricular dilated 
cardiomyopathy has been described in both autosomal dominant and autosomal recessive 
forms, but only the recessive forms have a clear association with dilated cardiomyopathy. 
Histopathological features include hyperkeratosis, hypergranulosis, and acanthosis with no 
epidermolysis. Electron microscopic examination shows diminished desmosomes, clumped 
keratin filaments, and enlarged keratohyalin granules. The syndrome has been linked to 
mutations in desmoglein 1, desmoplakin, and keratin 1. Treatment may include keratolytics, 
oral retinoids, and surgical debridement. Striate PPK is known to be caused by 
heterozygous mutations in either the desmoglein 1 (type I striate PPK), desmoplakin (type II 
striate PPK) or keratin 1 (type III striate PPK) gene [17-20]. 
5. Punctate type 
5.1. Buschke-Fischer syndrome 
Buschke-Fischer syndrome is an autosomal dominant disorder characterized by multiple 
punctate keratoses over the entire palmoplantar surfaces [21]. Punctate PPK presents as 
asymptomatic, tiny, hyperkeratotic punctate papules on the palmoplantar surface. Many 
tiny "raindrop" keratoses involve the palmoplantar surface; skin lesions may involve the 
whole palmoplantar surface, or may be more restricted in their distribution. The prevalence 
is 1.17 cases per 100,000 population. The age of onset ranges between 12 and 30 years. 
This condition is usually manifested bilaterally as asymptomatic, tiny, hyperkeratotic 
punctate papules/plaque on the palmoplantar surface. The exact etiology of this disorder is 
not known, but a dual influence of genetic and environmental factors may trigger the 
disease. Nail abnormalities in the form of longitudinal ridging, onychorrhexis, 
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onychoschizia, trachyonychia, and notching can be seen. Clinically, asymptomatic, tiny, 
hyperkeratotic papules are present on the palmoplantar surface. Lesions are uncommon in 
childhood and usually manifest after age 20 years. This condition is not associated with 
hyperhidrosis. Patients commonly report pruritus. Most individuals lack associated 
features; however, spastic paralysis, ankylosing spondylitis, and facial sebaceous 
hyperplasia have been reported. An association with gastrointestinal and pulmonary 
malignancy is possible. 
Histological findings include substantial compact hyperkeratosis over a distinct area of 
epidermis, hypergranulosis, the presence of a cornoid lamella, and the absence of epidermal 
dyskeratosis or hydropic change, which help differentiate this condition from porokeratosis. 
Two punctate PPK loci have been found to map to 15q22-15q24 and to 8q24.13-8q24.21 [22, 
23]. Treatment includes keratolytics, topical salicylic acid, mechanical debridement, excision, 
and topical and systemic retinoids. 
6. Remarks 
Hereditary PPK constitutes a heterogeneous group of disorders characterized by thickening 
of the palms and the soles of individuals who are affected. The diagnosis and classification 
are difficult due to inter-individual and intra-individual variations and differences in 
nomenclature. Dermatologists must be alert during the evaluation of these findings to ensure 
proper diagnosis, and must perform complete dermatological examination including nails, 
hair, and mucosa. In addition, future studies should include either a whole genome mapping 
plan or focus directly on candidate genes, such as SLURP1 gene for differential diagnosis 
between Mal de Meleda and Nagashima-type PPK. More reports and concise clinical 
observations with genetic approach may reveal the pathomechanism underlying PPK. 
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